Pioglitazone 2-Imine

We are Pioglitazone 2-Imine CAS:105355-26-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:Pioglitazone 2-Imine
CAS.NO:105355-26-8
Synonyms:Pioglitazone 2-Imine
5-[4-[2-(5-Ethyl-2-pyridyl)ethoxy]benzyl]-2-imino-4-thiazolidinone
2-Amino-5-(4-(2-(5-ethylpyridin-2-yl)ethoxy)benzyl)thiazol-4(5H)-one
 
Physical and Chemical Properties:
Density 1.3±0.1 g/cm3
Boiling Point 557.4±60.0 °C at 760 mmHg
Melting Point 187-188ºC
Molecular Formula C19H21N3O2S
Molecular Weight 355.454
Flash Point 290.9±32.9 °C
 
Specification:
Appearance:Light yellow to light brown powder
Assay:≥98.0%
Single impurity:≤1.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Pioglitazone hydrochloride(CAS:112529-15-4).

Pioglitazone 2-Imine


Related News: In an August overhaul to its drug administration law, Beijing said conditional approval could be granted to some still-under-research medicines of “predictable” clinical value for life-threatening diseases for which effective treatment is not immediately available.dibenzofuran-2-ylboronic acid The intravenous form of rigosertib has been studied in Phase 1, 2, and 3 clinical trials involving more than 1000 patients, and is currently being evaluated in a randomized Phase 3 international INSPIRE trial for patients with HR-MDS after failure of HMA therapy.N4-acetylcytidine CAS:3768-18-1 Under the sub-licensing agreement, Mankind will market the drug under its own trademark while Glenmark will manufacture and supply it to the drug firm.87-91-2 Slower growth in pesticide intermediates weighed on industrial business. In the first three quarters, the company’s operating income was 2.977 billion yuan, a year-on-year increase of 2.57%.Multinational drugmakers usually cut the price of drugs when they go off-patent and face competition from generic versions, but such price drops were slow to happen in China, partially because many local drugmakers were unable to develop high-quality generic drugs to compete with off-patent branded drugs.

Related Products
Product Name
9-bromo-1-nonanol acetate View Details
Ethanethioic acid S-ethyl ester View Details
1,1-Dimethoxy-2-(2-methoxyethoxy)ethane View Details
2-Amino-6-(trifluoromethyl)pyridine manufacturer 2-(2-bromoethoxy)-1,3,5-trichlorobenzene manufacturer 3-Bromo-4-chloroaniline manufacturer Ethyl 4,4,4-trifluoroacetoacetate manufacturer 2-Deoxy-2,2-difluoro-D-erythro-pentafuranous-1-ulose-3,5-dibenzoate manufacturer